Cover Image

Dengue subclinical infection an antecedent to secondary Dengue

LOKESHWARI .

Abstract


Abstract : Dengue is a major public health problem. The            severity of Dengue infection depends on serotype of infecting virus, previous exposure of the patient to Dengue virus and age of the patient. Though most of the infections have a subclinical course, Dengue differs from them in causing a more severe and fatal infection instead of being protective during subsequent infections. This has been attributed to the immunological              enhancement. Mild and sub-clinical infections go unnoticed and unreported. Thus this study is focused on screening the family members of the Dengue infected cases for subclinical                   infection.This study was done over a period of 3 months. Blood samples from 102 asymptomatic family members of 51               laboratory confirmed cases of Dengue were screened for              Dengue IgM and IgG by immunocapture ELISA on day 7 of identifying a case. WBC and platelet counts were done both in cases and asymptomatic family members. The subjects who were found to have Dengue IgM were tested for IgG antibody on day 14. On Day 7, out of 102 subjects screened, 34 were            positive for Dengue IgM and negative for IgG, 4 were positive for both IgM and IgG antibodies and 4 were positive for IgG alone. Leukocyte and platelet counts of these 42 subjects were normal. 3434 subjects were positive for IgG antibody on day 14. The highest percentage of subclinical infection was found in the age group of 2 to 4 years. There is a 37.3 prevalence of          subclinical Dengue infection among the asymptomatic family members of the Dengue confirmed cases screened. The younger children showed a higher percentage of subclinical infection than older children. Mere presence of IgM antibody is not sufficient for the diagnosis of Acute Dengue. The importance has to be laid on the clinical presentation and blood counts in the diagnosis of Dengue because Dengue antibodies are             produced in subclinical cases also. The knowledge of             prevalence of subclinical infection also helps in suspecting  secondary Dengue infection even if patients present for the first time with symptoms suggestive of Dengue.

 


Full Text:

PDF

References


Nivedita Gupta, Sakshi Srivastava, Amita Jain & Umesh C. Chaturvedi. Dengue in India. Indian J Med Res September 2012;136:p373-390.

P. Gunasekaran, K. Kaveri, S. Mohana, Kavita Arunagiri, B.V. Suresh Babu, P. Padma Priya, R. Kiruba, V. Senthil Kumar & A. Khaleefathullah Sheriff. Dengue disease status in Chennai (2006 - 2008): A retrospective analysis. Indian J Med Res March 2011;13:p 322-325.

Atul Garg, Jaya Garg, Y. K. Rao, G. C. Upadhyay and Suman Sakhuja. 2011, Prevalence of Dengue among clinically suspected febrile episodes at a teaching hospital in North India. Journal of Infectious Diseases and Immunity May 2011;Vol.3(5):p.85-89.

T. John Victor, M. Malathi, R. Asokan & P. Padmanaban. Laboratory-based Dengue fever surveillance in Tamil Nadu, India.Indian J Med Res August 2007;126:p.112-115.

Tomas Jelinek. Dengue Fever in International Travelers. Clinical Infectious Diseases July 2000; 31:p.144–7.

David W. Vaughn. Dengue Lessons from Cuba. American Journal of Epidemiology June 2000; 152:No.9. p.800-803.

Dengue haemorrhagicfever: diagno sis,treatment,prevention.2ndedition.WHO,Geneva, 1997;Chapter 4.p.34 – 47.

Ole Wichmann, Klaus Stark, Pei-Yun Shu,Matthias Niedrig,Christina Frank, Jyh-Hsiung Huang and Tomas Jelinek. Clinical features and pitfalls in the laboratory diagnosis of Dengue in travelers. BMC Infectious Diseases July 2006;6:120.p.1471-2334.

Nanthakorn Eu-Ahsunthornwattana, Jakris Euahsunthornwattana and Usa Thisyakorn. Peripheral blood count for Dengue severity prediction: A prospective study in Thai children. Pediatrics 2008;121.

James A. Potts and Alan L. Rothman. Clinical and laboratory features that distinguish Dengue from other febrile illnesses in endemic populations. Trop Med Int Health November 2008;13:11.p.1328–1340.

G N Malavige, S Fernando, D J Fernando, S L Seneviratne. Dengue viral infections. Postgraduate Medical Journal March 2004;80:p.588-601.

Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever.WHO 2011;p.18 – 30.

Stephen J.Mc Phee,Maxine A.Papadakis,Lawrence M.Tienney,JR.Current Medical Diagnosis and Treatment 2012;51st ed.p.1350.

Stephen J.Mc Phee,Maxine A.Papadakis, Lawrence M.Tienney,JR.Current Medical Diagnosis and Treatment 2008;47th ed.p.1205.

Kurukumbi M, Wali JP, Broor S, Aggarwal P, Seth P, Handa R, Dhar L, Vajapayee M. Seroepidemiology and active surveillance of Dengue fever/Dengue haemorrhagic fever in Delhi. Indian J Med Sci March 2001; 55:3.p.149-56.

G.N. Malavigea,Sirimali Fernandoa,John Aaskovb,S. Sivayoganc,ThushariDissanayakaa, Mallika K. Peelawattagea and Mahesha Dabarea Seroprevalence of Anti-dengue Virus Antibodies in Children in Colombo District, Sri Lanka.Dengue Bulletin 2006;Volume 30:p.68-71.

S.Kalayanarooj,S.Nimmannitya,S.Suntayakorn,D.E.Vaughn,A.Nisalak,S.Green, V.Chansiriwongs, A.Rothman, F.A.Ennis.Can Doctors Make an Accurate Diagnosis of Dengue Infections at an Early Stage? Dengue Bulletin December-1999;Volume 23


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University